Highlights Khiron Life Sciences Corp.

Equities

KHRN.H

CA49374L3065

Delayed Toronto S.E. Other stock markets 10:54:46 2023-05-05 am EDT			5-day change	1st Jan Change
0.04 ^CAD	-.--%		-.--%	-.--%

2023	Colombia's cannabis industry in crisis over regulatory, political hurdles	RE
2023	2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp..	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Colombia's cannabis industry in crisis over regulatory, political hurdles	Dec. 21	RE
2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp..	Nov. 16	CI
2518542 Alberta Ltd agreed to acquire Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp. for CAD 3 million.	23-07-27	CI
Khiron Life Sciences Corp. Enters into Partnership with an Accredited 3rd Party Contract Manufacturing Organization	23-04-20	CI
Khiron Life Sciences Starts Providing Insurance-covered Prescriptions in Colombia	23-01-19	MT
Khiron Edging Up as Notes NHS Reimburses Cost of Cannabis Treatment to First Zerenia Clinics UK Patient	23-01-16	MT
Khiron Life Sciences Corp. Announces Full Reimbursement by the NHS of Costs Associated to Cannabis-Based Medication and Clinic Fees for A Patient Enrolled in Zerenia Clinics UK	23-01-16	CI
Khiron Wins First Medical Cannabis Contract with Colombia's Largest Public Insurance Company	23-01-09	CI
Khiron Up 41% As Notes Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products	23-01-05	MT
Khiron Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-28	CI
Khiron Begins Sales in Switzerland, Increases Offerings in Germany, UK	22-11-16	MT
Khiron Life Sciences Corp. Begins Sales in Switzerland and Expands Its Medical Cannabis Portfolio in Germany and the United Kingdom	22-11-16	CI
Khiron Life Sciences Corp.'s Equity Buyback announced on September 9, 2021 has expired.	22-09-12	CI
Khiron Life Sciences Up 4% after Reporting Launch of New Cannabis Products in Europe	22-09-01	MT
Khiron Launches New Cannabis Products in Europe Including Stellar Genetics from California	22-09-01	CI
Khiron Life Sciences Second-Quarter Loss Narrows on Higher Sales	22-08-29	MT
Khiron Life Sciences Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Khiron Life Sciences Corp. Announces the Opening of Zerenia™ Clinic in Brazil, Rio De Janeiro	22-08-09	CI
Khiron Life Sciences Closes Purchase of Pharmadrug Production	22-08-03	MT
Khiron Life Sciences Corp. (TSXV:KHRN completed the acquisition of Pharmadrug Production GmbH from Pharmadrug Inc..	22-08-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Khiron Life Sciences Corp.

Equities

KHRN.H

CA49374L3065

Highlights

Filters